nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—UGT1A9—Irinotecan—colon cancer	0.102	0.168	CbGbCtD
Valproic Acid—SLC16A1—Methotrexate—colon cancer	0.0944	0.155	CbGbCtD
Valproic Acid—SLC22A7—Fluorouracil—colon cancer	0.0842	0.138	CbGbCtD
Valproic Acid—CYP2A6—Fluorouracil—colon cancer	0.0478	0.0786	CbGbCtD
Valproic Acid—SLC22A7—Methotrexate—colon cancer	0.0464	0.0763	CbGbCtD
Valproic Acid—CYP2B6—Irinotecan—colon cancer	0.0324	0.0533	CbGbCtD
Valproic Acid—SLC22A8—Methotrexate—colon cancer	0.0283	0.0466	CbGbCtD
Valproic Acid—CYP2C9—Capecitabine—colon cancer	0.0277	0.0456	CbGbCtD
Valproic Acid—CYP3A5—Irinotecan—colon cancer	0.0255	0.042	CbGbCtD
Valproic Acid—CYP2C8—Fluorouracil—colon cancer	0.0236	0.0387	CbGbCtD
Valproic Acid—CYP3A5—Vincristine—colon cancer	0.0223	0.0367	CbGbCtD
Valproic Acid—SLC22A6—Methotrexate—colon cancer	0.0197	0.0325	CbGbCtD
Valproic Acid—CYP1A2—Fluorouracil—colon cancer	0.0182	0.03	CbGbCtD
Valproic Acid—CYP2C9—Fluorouracil—colon cancer	0.0164	0.027	CbGbCtD
Valproic Acid—CYP3A4—Irinotecan—colon cancer	0.00996	0.0164	CbGbCtD
Valproic Acid—CYP3A4—Vincristine—colon cancer	0.0087	0.0143	CbGbCtD
Valproic Acid—UGT2B15—gall bladder—colon cancer	0.0046	0.0401	CbGeAlD
Valproic Acid—UGT1A10—renal system—colon cancer	0.00333	0.029	CbGeAlD
Valproic Acid—ALDH5A1—Vinblastine—Vincristine—colon cancer	0.00283	0.54	CbGdCrCtD
Valproic Acid—UGT1A10—digestive system—colon cancer	0.00273	0.0238	CbGeAlD
Valproic Acid—UGT1A8—renal system—colon cancer	0.00263	0.0229	CbGeAlD
Valproic Acid—UGT1A6—digestive system—colon cancer	0.00254	0.0221	CbGeAlD
Valproic Acid—OGDH—renal system—colon cancer	0.00245	0.0213	CbGeAlD
Valproic Acid—HDAC2—Topotecan—Irinotecan—colon cancer	0.0024	0.46	CbGdCrCtD
Valproic Acid—UGT1A8—digestive system—colon cancer	0.00216	0.0188	CbGeAlD
Valproic Acid—UGT1A10—liver—colon cancer	0.00204	0.0177	CbGeAlD
Valproic Acid—OGDH—lymphoid tissue—colon cancer	0.00203	0.0177	CbGeAlD
Valproic Acid—OGDH—digestive system—colon cancer	0.00201	0.0175	CbGeAlD
Valproic Acid—UGT1A4—renal system—colon cancer	0.002	0.0174	CbGeAlD
Valproic Acid—ACADSB—renal system—colon cancer	0.00194	0.0169	CbGeAlD
Valproic Acid—UGT1A3—digestive system—colon cancer	0.00193	0.0168	CbGeAlD
Valproic Acid—UGT1A6—liver—colon cancer	0.00189	0.0165	CbGeAlD
Valproic Acid—OGDH—bone marrow—colon cancer	0.00185	0.0161	CbGeAlD
Valproic Acid—UGT2B15—digestive system—colon cancer	0.00181	0.0158	CbGeAlD
Valproic Acid—HDAC9—lymphoid tissue—colon cancer	0.00179	0.0156	CbGeAlD
Valproic Acid—ALDH5A1—renal system—colon cancer	0.00171	0.0149	CbGeAlD
Valproic Acid—UGT1A9—renal system—colon cancer	0.00167	0.0146	CbGeAlD
Valproic Acid—UGT1A4—digestive system—colon cancer	0.00164	0.0143	CbGeAlD
Valproic Acid—HDAC9—bone marrow—colon cancer	0.00163	0.0142	CbGeAlD
Valproic Acid—UGT1A8—liver—colon cancer	0.00161	0.014	CbGeAlD
Valproic Acid—ACADSB—digestive system—colon cancer	0.0016	0.0139	CbGeAlD
Valproic Acid—OGDH—liver—colon cancer	0.0015	0.013	CbGeAlD
Valproic Acid—ACADSB—bone marrow—colon cancer	0.00147	0.0128	CbGeAlD
Valproic Acid—ABAT—renal system—colon cancer	0.00146	0.0128	CbGeAlD
Valproic Acid—HDAC2—embryo—colon cancer	0.00146	0.0127	CbGeAlD
Valproic Acid—UGT1A3—liver—colon cancer	0.00143	0.0125	CbGeAlD
Valproic Acid—ALDH5A1—lymphoid tissue—colon cancer	0.00142	0.0124	CbGeAlD
Valproic Acid—ACADSB—vagina—colon cancer	0.00141	0.0123	CbGeAlD
Valproic Acid—UGT1A9—digestive system—colon cancer	0.00137	0.012	CbGeAlD
Valproic Acid—UGT2B15—liver—colon cancer	0.00135	0.0117	CbGeAlD
Valproic Acid—UGT2B7—renal system—colon cancer	0.00135	0.0117	CbGeAlD
Valproic Acid—ALDH5A1—bone marrow—colon cancer	0.00129	0.0113	CbGeAlD
Valproic Acid—SLC22A7—renal system—colon cancer	0.00128	0.0112	CbGeAlD
Valproic Acid—ALDH5A1—vagina—colon cancer	0.00124	0.0108	CbGeAlD
Valproic Acid—UGT1A4—liver—colon cancer	0.00122	0.0106	CbGeAlD
Valproic Acid—CYP2C18—digestive system—colon cancer	0.0012	0.0104	CbGeAlD
Valproic Acid—HDAC2—epithelium—colon cancer	0.00119	0.0104	CbGeAlD
Valproic Acid—ACADSB—liver—colon cancer	0.00119	0.0104	CbGeAlD
Valproic Acid—OGDH—lymph node—colon cancer	0.00115	0.00999	CbGeAlD
Valproic Acid—HDAC2—smooth muscle tissue—colon cancer	0.00115	0.00999	CbGeAlD
Valproic Acid—UGT2B7—digestive system—colon cancer	0.00111	0.00963	CbGeAlD
Valproic Acid—HDAC2—renal system—colon cancer	0.0011	0.00961	CbGeAlD
Valproic Acid—ABAT—vagina—colon cancer	0.00106	0.00924	CbGeAlD
Valproic Acid—CYP2C18—vagina—colon cancer	0.00106	0.00923	CbGeAlD
Valproic Acid—SLC16A1—epithelium—colon cancer	0.00106	0.00921	CbGeAlD
Valproic Acid—PTGS1—endothelium—colon cancer	0.00106	0.0092	CbGeAlD
Valproic Acid—SLC22A7—digestive system—colon cancer	0.00105	0.00916	CbGeAlD
Valproic Acid—ALDH5A1—liver—colon cancer	0.00105	0.00912	CbGeAlD
Valproic Acid—UGT1A9—liver—colon cancer	0.00102	0.0089	CbGeAlD
Valproic Acid—HDAC9—lymph node—colon cancer	0.00101	0.00881	CbGeAlD
Valproic Acid—SLC16A1—renal system—colon cancer	0.000981	0.00854	CbGeAlD
Valproic Acid—PTGS1—blood vessel—colon cancer	0.000974	0.00849	CbGeAlD
Valproic Acid—HDAC2—lymphoid tissue—colon cancer	0.000916	0.00798	CbGeAlD
Valproic Acid—ACADSB—lymph node—colon cancer	0.000911	0.00794	CbGeAlD
Valproic Acid—HDAC2—digestive system—colon cancer	0.000905	0.00789	CbGeAlD
Valproic Acid—ABAT—liver—colon cancer	0.000895	0.0078	CbGeAlD
Valproic Acid—CYP2C18—liver—colon cancer	0.000893	0.00778	CbGeAlD
Valproic Acid—HDAC2—bone marrow—colon cancer	0.000834	0.00727	CbGeAlD
Valproic Acid—UGT2B7—liver—colon cancer	0.000824	0.00718	CbGeAlD
Valproic Acid—SLC16A1—digestive system—colon cancer	0.000804	0.00701	CbGeAlD
Valproic Acid—ALDH5A1—lymph node—colon cancer	0.000802	0.00699	CbGeAlD
Valproic Acid—HDAC2—vagina—colon cancer	0.000799	0.00696	CbGeAlD
Valproic Acid—SLC22A7—liver—colon cancer	0.000784	0.00683	CbGeAlD
Valproic Acid—SLC22A8—renal system—colon cancer	0.000741	0.00646	CbGeAlD
Valproic Acid—CYP2A6—vagina—colon cancer	0.0007	0.0061	CbGeAlD
Valproic Acid—ABAT—lymph node—colon cancer	0.000686	0.00598	CbGeAlD
Valproic Acid—HDAC2—liver—colon cancer	0.000674	0.00587	CbGeAlD
Valproic Acid—SLC16A1—liver—colon cancer	0.000599	0.00522	CbGeAlD
Valproic Acid—CYP2A6—liver—colon cancer	0.00059	0.00514	CbGeAlD
Valproic Acid—SLC22A5—renal system—colon cancer	0.00056	0.00488	CbGeAlD
Valproic Acid—CYP2C8—renal system—colon cancer	0.000542	0.00473	CbGeAlD
Valproic Acid—HDAC2—lymph node—colon cancer	0.000517	0.0045	CbGeAlD
Valproic Acid—CYP2C19—digestive system—colon cancer	0.00051	0.00444	CbGeAlD
Valproic Acid—CYP1A2—renal system—colon cancer	0.000508	0.00442	CbGeAlD
Valproic Acid—CYP3A5—renal system—colon cancer	0.00049	0.00427	CbGeAlD
Valproic Acid—CYP2B6—renal system—colon cancer	0.000486	0.00424	CbGeAlD
Valproic Acid—PTGS1—epithelium—colon cancer	0.000474	0.00413	CbGeAlD
Valproic Acid—SLC22A5—digestive system—colon cancer	0.000459	0.004	CbGeAlD
Valproic Acid—SLC16A1—lymph node—colon cancer	0.000459	0.004	CbGeAlD
Valproic Acid—PTGS1—smooth muscle tissue—colon cancer	0.000457	0.00398	CbGeAlD
Valproic Acid—CYP2C19—vagina—colon cancer	0.00045	0.00392	CbGeAlD
Valproic Acid—PTGS1—renal system—colon cancer	0.00044	0.00383	CbGeAlD
Valproic Acid—CYP1A2—digestive system—colon cancer	0.000416	0.00363	CbGeAlD
Valproic Acid—SLC22A5—vagina—colon cancer	0.000406	0.00354	CbGeAlD
Valproic Acid—CYP2B6—lymphoid tissue—colon cancer	0.000404	0.00352	CbGeAlD
Valproic Acid—CYP3A5—digestive system—colon cancer	0.000401	0.0035	CbGeAlD
Valproic Acid—CYP2B6—digestive system—colon cancer	0.000399	0.00348	CbGeAlD
Valproic Acid—CYP2C9—digestive system—colon cancer	0.000395	0.00344	CbGeAlD
Valproic Acid—CYP2C8—vagina—colon cancer	0.000393	0.00342	CbGeAlD
Valproic Acid—CYP2C19—liver—colon cancer	0.00038	0.00331	CbGeAlD
Valproic Acid—CYP3A4—renal system—colon cancer	0.000367	0.0032	CbGeAlD
Valproic Acid—PTGS1—digestive system—colon cancer	0.000361	0.00314	CbGeAlD
Valproic Acid—CYP3A5—vagina—colon cancer	0.000355	0.00309	CbGeAlD
Valproic Acid—CYP2B6—vagina—colon cancer	0.000352	0.00307	CbGeAlD
Valproic Acid—SLC22A5—liver—colon cancer	0.000342	0.00298	CbGeAlD
Valproic Acid—CYP2C8—liver—colon cancer	0.000331	0.00289	CbGeAlD
Valproic Acid—PTGS1—vagina—colon cancer	0.000319	0.00278	CbGeAlD
Valproic Acid—CYP1A2—liver—colon cancer	0.00031	0.0027	CbGeAlD
Valproic Acid—CYP3A4—digestive system—colon cancer	0.000301	0.00263	CbGeAlD
Valproic Acid—CYP3A5—liver—colon cancer	0.000299	0.00261	CbGeAlD
Valproic Acid—CYP2B6—liver—colon cancer	0.000297	0.00259	CbGeAlD
Valproic Acid—CYP2C9—liver—colon cancer	0.000294	0.00256	CbGeAlD
Valproic Acid—SLC22A5—lymph node—colon cancer	0.000262	0.00229	CbGeAlD
Valproic Acid—Chest pain—Fluorouracil—colon cancer	0.000246	0.00136	CcSEcCtD
Valproic Acid—Infection—Irinotecan—colon cancer	0.000245	0.00135	CcSEcCtD
Valproic Acid—Hyperhidrosis—Vincristine—colon cancer	0.000245	0.00135	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Capecitabine—colon cancer	0.000245	0.00135	CcSEcCtD
Valproic Acid—Epistaxis—Capecitabine—colon cancer	0.000244	0.00135	CcSEcCtD
Valproic Acid—Discomfort—Fluorouracil—colon cancer	0.000243	0.00134	CcSEcCtD
Valproic Acid—Nervous system disorder—Irinotecan—colon cancer	0.000242	0.00133	CcSEcCtD
Valproic Acid—Agranulocytosis—Capecitabine—colon cancer	0.000242	0.00133	CcSEcCtD
Valproic Acid—Thrombocytopenia—Irinotecan—colon cancer	0.000242	0.00133	CcSEcCtD
Valproic Acid—Anorexia—Vincristine—colon cancer	0.000241	0.00133	CcSEcCtD
Valproic Acid—Hyperhidrosis—Irinotecan—colon cancer	0.000238	0.00131	CcSEcCtD
Valproic Acid—Confusional state—Fluorouracil—colon cancer	0.000238	0.00131	CcSEcCtD
Valproic Acid—Mood swings—Methotrexate—colon cancer	0.000237	0.00131	CcSEcCtD
Valproic Acid—Hypotension—Vincristine—colon cancer	0.000237	0.0013	CcSEcCtD
Valproic Acid—Bradycardia—Capecitabine—colon cancer	0.000237	0.0013	CcSEcCtD
Valproic Acid—Oedema—Fluorouracil—colon cancer	0.000236	0.0013	CcSEcCtD
Valproic Acid—Anaphylactic shock—Fluorouracil—colon cancer	0.000236	0.0013	CcSEcCtD
Valproic Acid—Anorexia—Irinotecan—colon cancer	0.000235	0.0013	CcSEcCtD
Valproic Acid—Ataxia—Methotrexate—colon cancer	0.000235	0.0013	CcSEcCtD
Valproic Acid—Infection—Fluorouracil—colon cancer	0.000235	0.00129	CcSEcCtD
Valproic Acid—Haemoglobin—Capecitabine—colon cancer	0.000234	0.00129	CcSEcCtD
Valproic Acid—Rhinitis—Capecitabine—colon cancer	0.000233	0.00128	CcSEcCtD
Valproic Acid—Haemorrhage—Capecitabine—colon cancer	0.000232	0.00128	CcSEcCtD
Valproic Acid—Nervous system disorder—Fluorouracil—colon cancer	0.000232	0.00128	CcSEcCtD
Valproic Acid—Thrombocytopenia—Fluorouracil—colon cancer	0.000231	0.00128	CcSEcCtD
Valproic Acid—Hypoaesthesia—Capecitabine—colon cancer	0.000231	0.00127	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Vincristine—colon cancer	0.000231	0.00127	CcSEcCtD
Valproic Acid—Pharyngitis—Capecitabine—colon cancer	0.000231	0.00127	CcSEcCtD
Valproic Acid—Tachycardia—Fluorouracil—colon cancer	0.000231	0.00127	CcSEcCtD
Valproic Acid—Hypotension—Irinotecan—colon cancer	0.00023	0.00127	CcSEcCtD
Valproic Acid—Urinary tract disorder—Capecitabine—colon cancer	0.000229	0.00126	CcSEcCtD
Valproic Acid—Insomnia—Vincristine—colon cancer	0.000229	0.00126	CcSEcCtD
Valproic Acid—Oedema peripheral—Capecitabine—colon cancer	0.000229	0.00126	CcSEcCtD
Valproic Acid—Connective tissue disorder—Capecitabine—colon cancer	0.000228	0.00126	CcSEcCtD
Valproic Acid—Urethral disorder—Capecitabine—colon cancer	0.000228	0.00126	CcSEcCtD
Valproic Acid—Paraesthesia—Vincristine—colon cancer	0.000227	0.00125	CcSEcCtD
Valproic Acid—Breast disorder—Methotrexate—colon cancer	0.000226	0.00125	CcSEcCtD
Valproic Acid—Anorexia—Fluorouracil—colon cancer	0.000225	0.00124	CcSEcCtD
Valproic Acid—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000225	0.00124	CcSEcCtD
Valproic Acid—CYP3A4—liver—colon cancer	0.000224	0.00196	CbGeAlD
Valproic Acid—Visual impairment—Capecitabine—colon cancer	0.000224	0.00123	CcSEcCtD
Valproic Acid—Insomnia—Irinotecan—colon cancer	0.000223	0.00123	CcSEcCtD
Valproic Acid—Paraesthesia—Irinotecan—colon cancer	0.000221	0.00122	CcSEcCtD
Valproic Acid—Hypotension—Fluorouracil—colon cancer	0.000221	0.00122	CcSEcCtD
Valproic Acid—Decreased appetite—Vincristine—colon cancer	0.00022	0.00121	CcSEcCtD
Valproic Acid—Dyspnoea—Irinotecan—colon cancer	0.00022	0.00121	CcSEcCtD
Valproic Acid—Erythema multiforme—Capecitabine—colon cancer	0.00022	0.00121	CcSEcCtD
Valproic Acid—Somnolence—Irinotecan—colon cancer	0.000219	0.00121	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Vincristine—colon cancer	0.000219	0.00121	CcSEcCtD
Valproic Acid—Fatigue—Vincristine—colon cancer	0.000218	0.0012	CcSEcCtD
Valproic Acid—Eye disorder—Capecitabine—colon cancer	0.000217	0.0012	CcSEcCtD
Valproic Acid—Dyspepsia—Irinotecan—colon cancer	0.000217	0.0012	CcSEcCtD
Valproic Acid—Tinnitus—Capecitabine—colon cancer	0.000217	0.00119	CcSEcCtD
Valproic Acid—Pain—Vincristine—colon cancer	0.000217	0.00119	CcSEcCtD
Valproic Acid—Constipation—Vincristine—colon cancer	0.000217	0.00119	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000215	0.00119	CcSEcCtD
Valproic Acid—Decreased appetite—Irinotecan—colon cancer	0.000214	0.00118	CcSEcCtD
Valproic Acid—Eosinophilia—Methotrexate—colon cancer	0.000214	0.00118	CcSEcCtD
Valproic Acid—Insomnia—Fluorouracil—colon cancer	0.000214	0.00118	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Irinotecan—colon cancer	0.000213	0.00117	CcSEcCtD
Valproic Acid—Fatigue—Irinotecan—colon cancer	0.000213	0.00117	CcSEcCtD
Valproic Acid—Paraesthesia—Fluorouracil—colon cancer	0.000212	0.00117	CcSEcCtD
Valproic Acid—Pancreatitis—Methotrexate—colon cancer	0.000212	0.00117	CcSEcCtD
Valproic Acid—Constipation—Irinotecan—colon cancer	0.000211	0.00116	CcSEcCtD
Valproic Acid—Pain—Irinotecan—colon cancer	0.000211	0.00116	CcSEcCtD
Valproic Acid—Angiopathy—Capecitabine—colon cancer	0.000211	0.00116	CcSEcCtD
Valproic Acid—Dyspnoea—Fluorouracil—colon cancer	0.000211	0.00116	CcSEcCtD
Valproic Acid—Somnolence—Fluorouracil—colon cancer	0.00021	0.00116	CcSEcCtD
Valproic Acid—Immune system disorder—Capecitabine—colon cancer	0.00021	0.00116	CcSEcCtD
Valproic Acid—Mediastinal disorder—Capecitabine—colon cancer	0.000209	0.00115	CcSEcCtD
Valproic Acid—Chills—Capecitabine—colon cancer	0.000208	0.00115	CcSEcCtD
Valproic Acid—Dyspepsia—Fluorouracil—colon cancer	0.000208	0.00115	CcSEcCtD
Valproic Acid—Arrhythmia—Capecitabine—colon cancer	0.000208	0.00114	CcSEcCtD
Valproic Acid—Abdominal discomfort—Methotrexate—colon cancer	0.000207	0.00114	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Vincristine—colon cancer	0.000207	0.00114	CcSEcCtD
Valproic Acid—PTGS1—lymph node—colon cancer	0.000206	0.0018	CbGeAlD
Valproic Acid—Decreased appetite—Fluorouracil—colon cancer	0.000205	0.00113	CcSEcCtD
Valproic Acid—Alopecia—Capecitabine—colon cancer	0.000205	0.00113	CcSEcCtD
Valproic Acid—Pancytopenia—Methotrexate—colon cancer	0.000205	0.00113	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000204	0.00112	CcSEcCtD
Valproic Acid—Mental disorder—Capecitabine—colon cancer	0.000204	0.00112	CcSEcCtD
Valproic Acid—Feeling abnormal—Irinotecan—colon cancer	0.000203	0.00112	CcSEcCtD
Valproic Acid—Malnutrition—Capecitabine—colon cancer	0.000202	0.00112	CcSEcCtD
Valproic Acid—Neutropenia—Methotrexate—colon cancer	0.000202	0.00111	CcSEcCtD
Valproic Acid—Dysuria—Methotrexate—colon cancer	0.000202	0.00111	CcSEcCtD
Valproic Acid—Pain—Fluorouracil—colon cancer	0.000202	0.00111	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Irinotecan—colon cancer	0.000202	0.00111	CcSEcCtD
Valproic Acid—Abdominal pain—Vincristine—colon cancer	0.0002	0.0011	CcSEcCtD
Valproic Acid—Body temperature increased—Vincristine—colon cancer	0.0002	0.0011	CcSEcCtD
Valproic Acid—Flatulence—Capecitabine—colon cancer	0.000199	0.0011	CcSEcCtD
Valproic Acid—Dysgeusia—Capecitabine—colon cancer	0.000198	0.00109	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Methotrexate—colon cancer	0.000197	0.00109	CcSEcCtD
Valproic Acid—Back pain—Capecitabine—colon cancer	0.000196	0.00108	CcSEcCtD
Valproic Acid—Body temperature increased—Irinotecan—colon cancer	0.000195	0.00107	CcSEcCtD
Valproic Acid—Abdominal pain—Irinotecan—colon cancer	0.000195	0.00107	CcSEcCtD
Valproic Acid—Feeling abnormal—Fluorouracil—colon cancer	0.000195	0.00107	CcSEcCtD
Valproic Acid—Muscle spasms—Capecitabine—colon cancer	0.000194	0.00107	CcSEcCtD
Valproic Acid—Pneumonia—Methotrexate—colon cancer	0.000194	0.00107	CcSEcCtD
Valproic Acid—Drowsiness—Methotrexate—colon cancer	0.000193	0.00106	CcSEcCtD
Valproic Acid—Depression—Methotrexate—colon cancer	0.000192	0.00106	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000191	0.00105	CcSEcCtD
Valproic Acid—Vision blurred—Capecitabine—colon cancer	0.000191	0.00105	CcSEcCtD
Valproic Acid—Tremor—Capecitabine—colon cancer	0.00019	0.00104	CcSEcCtD
Valproic Acid—Stomatitis—Methotrexate—colon cancer	0.000188	0.00104	CcSEcCtD
Valproic Acid—Ill-defined disorder—Capecitabine—colon cancer	0.000188	0.00103	CcSEcCtD
Valproic Acid—Urticaria—Fluorouracil—colon cancer	0.000188	0.00103	CcSEcCtD
Valproic Acid—Conjunctivitis—Methotrexate—colon cancer	0.000187	0.00103	CcSEcCtD
Valproic Acid—Anaemia—Capecitabine—colon cancer	0.000187	0.00103	CcSEcCtD
Valproic Acid—Body temperature increased—Fluorouracil—colon cancer	0.000187	0.00103	CcSEcCtD
Valproic Acid—Hypersensitivity—Vincristine—colon cancer	0.000187	0.00103	CcSEcCtD
Valproic Acid—Sweating—Methotrexate—colon cancer	0.000185	0.00102	CcSEcCtD
Valproic Acid—Malaise—Capecitabine—colon cancer	0.000182	0.00101	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Methotrexate—colon cancer	0.000182	0.001	CcSEcCtD
Valproic Acid—Epistaxis—Methotrexate—colon cancer	0.000182	0.001	CcSEcCtD
Valproic Acid—Vertigo—Capecitabine—colon cancer	0.000182	0.001	CcSEcCtD
Valproic Acid—Hypersensitivity—Irinotecan—colon cancer	0.000182	0.001	CcSEcCtD
Valproic Acid—Asthenia—Vincristine—colon cancer	0.000182	0.001	CcSEcCtD
Valproic Acid—Leukopenia—Capecitabine—colon cancer	0.000181	0.000998	CcSEcCtD
Valproic Acid—Agranulocytosis—Methotrexate—colon cancer	0.00018	0.000991	CcSEcCtD
Valproic Acid—Palpitations—Capecitabine—colon cancer	0.000179	0.000985	CcSEcCtD
Valproic Acid—Asthenia—Irinotecan—colon cancer	0.000177	0.000976	CcSEcCtD
Valproic Acid—Cough—Capecitabine—colon cancer	0.000177	0.000973	CcSEcCtD
Valproic Acid—Hypertension—Capecitabine—colon cancer	0.000175	0.000963	CcSEcCtD
Valproic Acid—Hypersensitivity—Fluorouracil—colon cancer	0.000174	0.000959	CcSEcCtD
Valproic Acid—Haemoglobin—Methotrexate—colon cancer	0.000174	0.000958	CcSEcCtD
Valproic Acid—Diarrhoea—Vincristine—colon cancer	0.000173	0.000955	CcSEcCtD
Valproic Acid—Haemorrhage—Methotrexate—colon cancer	0.000173	0.000954	CcSEcCtD
Valproic Acid—Chest pain—Capecitabine—colon cancer	0.000172	0.000949	CcSEcCtD
Valproic Acid—Myalgia—Capecitabine—colon cancer	0.000172	0.000949	CcSEcCtD
Valproic Acid—Arthralgia—Capecitabine—colon cancer	0.000172	0.000949	CcSEcCtD
Valproic Acid—Pharyngitis—Methotrexate—colon cancer	0.000172	0.000946	CcSEcCtD
Valproic Acid—Anxiety—Capecitabine—colon cancer	0.000172	0.000946	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000171	0.000943	CcSEcCtD
Valproic Acid—Urinary tract disorder—Methotrexate—colon cancer	0.000171	0.000942	CcSEcCtD
Valproic Acid—Discomfort—Capecitabine—colon cancer	0.00017	0.000938	CcSEcCtD
Valproic Acid—Urethral disorder—Methotrexate—colon cancer	0.00017	0.000935	CcSEcCtD
Valproic Acid—Diarrhoea—Irinotecan—colon cancer	0.000169	0.00093	CcSEcCtD
Valproic Acid—Dry mouth—Capecitabine—colon cancer	0.000168	0.000928	CcSEcCtD
Valproic Acid—Dizziness—Vincristine—colon cancer	0.000167	0.000923	CcSEcCtD
Valproic Acid—Pruritus—Fluorouracil—colon cancer	0.000167	0.000921	CcSEcCtD
Valproic Acid—Visual impairment—Methotrexate—colon cancer	0.000167	0.000919	CcSEcCtD
Valproic Acid—Confusional state—Capecitabine—colon cancer	0.000166	0.000918	CcSEcCtD
Valproic Acid—Oedema—Capecitabine—colon cancer	0.000165	0.00091	CcSEcCtD
Valproic Acid—Infection—Capecitabine—colon cancer	0.000164	0.000904	CcSEcCtD
Valproic Acid—Erythema multiforme—Methotrexate—colon cancer	0.000164	0.000902	CcSEcCtD
Valproic Acid—Dizziness—Irinotecan—colon cancer	0.000163	0.000899	CcSEcCtD
Valproic Acid—Nervous system disorder—Capecitabine—colon cancer	0.000162	0.000892	CcSEcCtD
Valproic Acid—Eye disorder—Methotrexate—colon cancer	0.000162	0.000891	CcSEcCtD
Valproic Acid—Diarrhoea—Fluorouracil—colon cancer	0.000162	0.000891	CcSEcCtD
Valproic Acid—Thrombocytopenia—Capecitabine—colon cancer	0.000162	0.000891	CcSEcCtD
Valproic Acid—Tinnitus—Methotrexate—colon cancer	0.000161	0.000889	CcSEcCtD
Valproic Acid—Tachycardia—Capecitabine—colon cancer	0.000161	0.000888	CcSEcCtD
Valproic Acid—Vomiting—Vincristine—colon cancer	0.000161	0.000888	CcSEcCtD
Valproic Acid—Skin disorder—Capecitabine—colon cancer	0.00016	0.000884	CcSEcCtD
Valproic Acid—Rash—Vincristine—colon cancer	0.00016	0.00088	CcSEcCtD
Valproic Acid—Hyperhidrosis—Capecitabine—colon cancer	0.00016	0.00088	CcSEcCtD
Valproic Acid—Dermatitis—Vincristine—colon cancer	0.00016	0.000879	CcSEcCtD
Valproic Acid—Headache—Vincristine—colon cancer	0.000159	0.000875	CcSEcCtD
Valproic Acid—Anorexia—Capecitabine—colon cancer	0.000157	0.000867	CcSEcCtD
Valproic Acid—Angiopathy—Methotrexate—colon cancer	0.000157	0.000865	CcSEcCtD
Valproic Acid—Vomiting—Irinotecan—colon cancer	0.000157	0.000864	CcSEcCtD
Valproic Acid—Immune system disorder—Methotrexate—colon cancer	0.000156	0.000861	CcSEcCtD
Valproic Acid—Dizziness—Fluorouracil—colon cancer	0.000156	0.000861	CcSEcCtD
Valproic Acid—Mediastinal disorder—Methotrexate—colon cancer	0.000156	0.000859	CcSEcCtD
Valproic Acid—Rash—Irinotecan—colon cancer	0.000156	0.000857	CcSEcCtD
Valproic Acid—Dermatitis—Irinotecan—colon cancer	0.000155	0.000856	CcSEcCtD
Valproic Acid—Chills—Methotrexate—colon cancer	0.000155	0.000856	CcSEcCtD
Valproic Acid—Headache—Irinotecan—colon cancer	0.000155	0.000852	CcSEcCtD
Valproic Acid—Hypotension—Capecitabine—colon cancer	0.000154	0.00085	CcSEcCtD
Valproic Acid—Alopecia—Methotrexate—colon cancer	0.000153	0.000843	CcSEcCtD
Valproic Acid—Mental disorder—Methotrexate—colon cancer	0.000152	0.000835	CcSEcCtD
Valproic Acid—Malnutrition—Methotrexate—colon cancer	0.000151	0.00083	CcSEcCtD
Valproic Acid—Nausea—Vincristine—colon cancer	0.00015	0.000829	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00015	0.000829	CcSEcCtD
Valproic Acid—Vomiting—Fluorouracil—colon cancer	0.00015	0.000828	CcSEcCtD
Valproic Acid—Insomnia—Capecitabine—colon cancer	0.000149	0.000823	CcSEcCtD
Valproic Acid—Rash—Fluorouracil—colon cancer	0.000149	0.000821	CcSEcCtD
Valproic Acid—Dermatitis—Fluorouracil—colon cancer	0.000149	0.00082	CcSEcCtD
Valproic Acid—Paraesthesia—Capecitabine—colon cancer	0.000148	0.000817	CcSEcCtD
Valproic Acid—Headache—Fluorouracil—colon cancer	0.000148	0.000816	CcSEcCtD
Valproic Acid—Dysgeusia—Methotrexate—colon cancer	0.000147	0.000813	CcSEcCtD
Valproic Acid—Dyspnoea—Capecitabine—colon cancer	0.000147	0.000811	CcSEcCtD
Valproic Acid—Nausea—Irinotecan—colon cancer	0.000147	0.000808	CcSEcCtD
Valproic Acid—Back pain—Methotrexate—colon cancer	0.000146	0.000803	CcSEcCtD
Valproic Acid—Dyspepsia—Capecitabine—colon cancer	0.000145	0.000801	CcSEcCtD
Valproic Acid—Decreased appetite—Capecitabine—colon cancer	0.000144	0.000791	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Capecitabine—colon cancer	0.000143	0.000786	CcSEcCtD
Valproic Acid—Fatigue—Capecitabine—colon cancer	0.000142	0.000785	CcSEcCtD
Valproic Acid—Vision blurred—Methotrexate—colon cancer	0.000142	0.000782	CcSEcCtD
Valproic Acid—Constipation—Capecitabine—colon cancer	0.000141	0.000778	CcSEcCtD
Valproic Acid—Pain—Capecitabine—colon cancer	0.000141	0.000778	CcSEcCtD
Valproic Acid—Nausea—Fluorouracil—colon cancer	0.00014	0.000774	CcSEcCtD
Valproic Acid—Ill-defined disorder—Methotrexate—colon cancer	0.00014	0.00077	CcSEcCtD
Valproic Acid—Anaemia—Methotrexate—colon cancer	0.000139	0.000767	CcSEcCtD
Valproic Acid—Feeling abnormal—Capecitabine—colon cancer	0.000136	0.00075	CcSEcCtD
Valproic Acid—Malaise—Methotrexate—colon cancer	0.000136	0.000749	CcSEcCtD
Valproic Acid—Vertigo—Methotrexate—colon cancer	0.000135	0.000746	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Capecitabine—colon cancer	0.000135	0.000744	CcSEcCtD
Valproic Acid—Leukopenia—Methotrexate—colon cancer	0.000135	0.000743	CcSEcCtD
Valproic Acid—Cough—Methotrexate—colon cancer	0.000131	0.000724	CcSEcCtD
Valproic Acid—Urticaria—Capecitabine—colon cancer	0.000131	0.000723	CcSEcCtD
Valproic Acid—Abdominal pain—Capecitabine—colon cancer	0.000131	0.000719	CcSEcCtD
Valproic Acid—Body temperature increased—Capecitabine—colon cancer	0.000131	0.000719	CcSEcCtD
Valproic Acid—Arthralgia—Methotrexate—colon cancer	0.000128	0.000707	CcSEcCtD
Valproic Acid—Chest pain—Methotrexate—colon cancer	0.000128	0.000707	CcSEcCtD
Valproic Acid—Myalgia—Methotrexate—colon cancer	0.000128	0.000707	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000127	0.000702	CcSEcCtD
Valproic Acid—Discomfort—Methotrexate—colon cancer	0.000127	0.000698	CcSEcCtD
Valproic Acid—Confusional state—Methotrexate—colon cancer	0.000124	0.000683	CcSEcCtD
Valproic Acid—Anaphylactic shock—Methotrexate—colon cancer	0.000123	0.000677	CcSEcCtD
Valproic Acid—Infection—Methotrexate—colon cancer	0.000122	0.000673	CcSEcCtD
Valproic Acid—Hypersensitivity—Capecitabine—colon cancer	0.000122	0.00067	CcSEcCtD
Valproic Acid—Nervous system disorder—Methotrexate—colon cancer	0.000121	0.000664	CcSEcCtD
Valproic Acid—Thrombocytopenia—Methotrexate—colon cancer	0.00012	0.000663	CcSEcCtD
Valproic Acid—Skin disorder—Methotrexate—colon cancer	0.000119	0.000658	CcSEcCtD
Valproic Acid—Hyperhidrosis—Methotrexate—colon cancer	0.000119	0.000655	CcSEcCtD
Valproic Acid—Asthenia—Capecitabine—colon cancer	0.000118	0.000653	CcSEcCtD
Valproic Acid—Anorexia—Methotrexate—colon cancer	0.000117	0.000646	CcSEcCtD
Valproic Acid—Pruritus—Capecitabine—colon cancer	0.000117	0.000644	CcSEcCtD
Valproic Acid—Hypotension—Methotrexate—colon cancer	0.000115	0.000633	CcSEcCtD
Valproic Acid—Diarrhoea—Capecitabine—colon cancer	0.000113	0.000623	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000112	0.000617	CcSEcCtD
Valproic Acid—Insomnia—Methotrexate—colon cancer	0.000111	0.000613	CcSEcCtD
Valproic Acid—Paraesthesia—Methotrexate—colon cancer	0.00011	0.000608	CcSEcCtD
Valproic Acid—Dyspnoea—Methotrexate—colon cancer	0.00011	0.000604	CcSEcCtD
Valproic Acid—Somnolence—Methotrexate—colon cancer	0.000109	0.000602	CcSEcCtD
Valproic Acid—Dizziness—Capecitabine—colon cancer	0.000109	0.000602	CcSEcCtD
Valproic Acid—Dyspepsia—Methotrexate—colon cancer	0.000108	0.000596	CcSEcCtD
Valproic Acid—Decreased appetite—Methotrexate—colon cancer	0.000107	0.000589	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Methotrexate—colon cancer	0.000106	0.000585	CcSEcCtD
Valproic Acid—Fatigue—Methotrexate—colon cancer	0.000106	0.000584	CcSEcCtD
Valproic Acid—Pain—Methotrexate—colon cancer	0.000105	0.000579	CcSEcCtD
Valproic Acid—Vomiting—Capecitabine—colon cancer	0.000105	0.000579	CcSEcCtD
Valproic Acid—Rash—Capecitabine—colon cancer	0.000104	0.000574	CcSEcCtD
Valproic Acid—Dermatitis—Capecitabine—colon cancer	0.000104	0.000573	CcSEcCtD
Valproic Acid—Headache—Capecitabine—colon cancer	0.000103	0.00057	CcSEcCtD
Valproic Acid—Feeling abnormal—Methotrexate—colon cancer	0.000101	0.000558	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Methotrexate—colon cancer	0.0001	0.000554	CcSEcCtD
Valproic Acid—Nausea—Capecitabine—colon cancer	9.81e-05	0.000541	CcSEcCtD
Valproic Acid—Urticaria—Methotrexate—colon cancer	9.76e-05	0.000538	CcSEcCtD
Valproic Acid—Body temperature increased—Methotrexate—colon cancer	9.72e-05	0.000536	CcSEcCtD
Valproic Acid—Abdominal pain—Methotrexate—colon cancer	9.72e-05	0.000536	CcSEcCtD
Valproic Acid—Hypersensitivity—Methotrexate—colon cancer	9.05e-05	0.000499	CcSEcCtD
Valproic Acid—Asthenia—Methotrexate—colon cancer	8.82e-05	0.000486	CcSEcCtD
Valproic Acid—Pruritus—Methotrexate—colon cancer	8.69e-05	0.000479	CcSEcCtD
Valproic Acid—Diarrhoea—Methotrexate—colon cancer	8.41e-05	0.000464	CcSEcCtD
Valproic Acid—Dizziness—Methotrexate—colon cancer	8.13e-05	0.000448	CcSEcCtD
Valproic Acid—Vomiting—Methotrexate—colon cancer	7.81e-05	0.000431	CcSEcCtD
Valproic Acid—Rash—Methotrexate—colon cancer	7.75e-05	0.000427	CcSEcCtD
Valproic Acid—Dermatitis—Methotrexate—colon cancer	7.74e-05	0.000427	CcSEcCtD
Valproic Acid—Headache—Methotrexate—colon cancer	7.7e-05	0.000424	CcSEcCtD
Valproic Acid—Nausea—Methotrexate—colon cancer	7.3e-05	0.000402	CcSEcCtD
Valproic Acid—CYP2C8—Metabolism—ODC1—colon cancer	3.84e-05	0.000426	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CHST5—colon cancer	3.84e-05	0.000426	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—PIK3CA—colon cancer	3.82e-05	0.000423	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—APC—colon cancer	3.8e-05	0.000421	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	3.69e-05	0.000409	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—CTNNB1—colon cancer	3.69e-05	0.000409	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PPARG—colon cancer	3.62e-05	0.000402	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—CDKN1A—colon cancer	3.61e-05	0.000399	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—PIK3CA—colon cancer	3.59e-05	0.000397	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—BRAF—colon cancer	3.58e-05	0.000396	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—EP300—colon cancer	3.43e-05	0.00038	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CHST5—colon cancer	3.43e-05	0.00038	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ODC1—colon cancer	3.43e-05	0.00038	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CA7—colon cancer	3.4e-05	0.000377	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—EP300—colon cancer	3.36e-05	0.000372	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ABCB1—colon cancer	3.36e-05	0.000372	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—SRC—colon cancer	3.34e-05	0.00037	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—HRAS—colon cancer	3.32e-05	0.000368	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—TYMS—colon cancer	3.3e-05	0.000365	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—SRC—colon cancer	3.27e-05	0.000362	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—PTGS2—colon cancer	3.26e-05	0.000361	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—PIK3CA—colon cancer	3.25e-05	0.00036	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—NRAS—colon cancer	3.21e-05	0.000356	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—VEGFA—colon cancer	3.18e-05	0.000352	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—NRAS—colon cancer	3.14e-05	0.000348	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CHST5—colon cancer	3.13e-05	0.000346	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ODC1—colon cancer	3.13e-05	0.000346	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—AKT1—colon cancer	3.12e-05	0.000346	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—EP300—colon cancer	3.07e-05	0.00034	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PPARG—colon cancer	3.03e-05	0.000335	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.01e-05	0.000334	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—ABCB1—colon cancer	2.99e-05	0.000331	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—MYC—colon cancer	2.99e-05	0.000331	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—SRC—colon cancer	2.99e-05	0.000331	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—TGFB1—colon cancer	2.98e-05	0.00033	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—TYMS—colon cancer	2.94e-05	0.000326	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—AKT1—colon cancer	2.93e-05	0.000325	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—EGFR—colon cancer	2.92e-05	0.000324	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TGFB1—colon cancer	2.92e-05	0.000324	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—VEGFA—colon cancer	2.91e-05	0.000322	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—NRAS—colon cancer	2.87e-05	0.000318	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PTGS2—colon cancer	2.85e-05	0.000316	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—ABCB1—colon cancer	2.79e-05	0.000309	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—KRAS—colon cancer	2.76e-05	0.000306	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—TYMS—colon cancer	2.74e-05	0.000304	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—EP300—colon cancer	2.71e-05	0.000301	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—KRAS—colon cancer	2.71e-05	0.0003	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CASP3—colon cancer	2.68e-05	0.000297	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CHST5—colon cancer	2.67e-05	0.000296	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ODC1—colon cancer	2.67e-05	0.000296	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TGFB1—colon cancer	2.67e-05	0.000296	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—AKT1—colon cancer	2.65e-05	0.000294	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCND1—colon cancer	2.61e-05	0.000289	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CTNNB1—colon cancer	2.58e-05	0.000286	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—FGFR3—colon cancer	2.57e-05	0.000284	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—PIK3CA—colon cancer	2.54e-05	0.000281	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CDKN1A—colon cancer	2.52e-05	0.00028	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—PIK3CA—colon cancer	2.49e-05	0.000275	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—KRAS—colon cancer	2.47e-05	0.000274	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.46e-05	0.000272	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—PPARG—colon cancer	2.45e-05	0.000271	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ABCB1—colon cancer	2.44e-05	0.00027	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TP53—colon cancer	2.4e-05	0.000266	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—EP300—colon cancer	2.4e-05	0.000266	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—TYMS—colon cancer	2.4e-05	0.000265	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PTGS2—colon cancer	2.38e-05	0.000264	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ABCB1—colon cancer	2.37e-05	0.000263	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—EP300—colon cancer	2.37e-05	0.000263	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.37e-05	0.000263	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—APC—colon cancer	2.36e-05	0.000261	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—HRAS—colon cancer	2.35e-05	0.00026	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—SRC—colon cancer	2.34e-05	0.000259	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PPARG—colon cancer	2.34e-05	0.000259	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—TYMS—colon cancer	2.33e-05	0.000258	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—HRAS—colon cancer	2.3e-05	0.000255	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—VEGFA—colon cancer	2.28e-05	0.000252	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—PIK3CA—colon cancer	2.27e-05	0.000252	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—NRAS—colon cancer	2.25e-05	0.000249	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—BRAF—colon cancer	2.21e-05	0.000245	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TP53—colon cancer	2.2e-05	0.000244	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—HRAS—colon cancer	2.1e-05	0.000233	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MYC—colon cancer	2.09e-05	0.000232	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TGFB1—colon cancer	2.09e-05	0.000231	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PPARG—colon cancer	2.08e-05	0.000231	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—AKT1—colon cancer	2.07e-05	0.00023	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CHST5—colon cancer	2.06e-05	0.000228	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ODC1—colon cancer	2.06e-05	0.000228	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—EGFR—colon cancer	2.05e-05	0.000227	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—AKT1—colon cancer	2.03e-05	0.000225	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—PIK3CA—colon cancer	2.01e-05	0.000222	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—EP300—colon cancer	1.98e-05	0.000219	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.97e-05	0.000218	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PPARG—colon cancer	1.94e-05	0.000215	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—KRAS—colon cancer	1.93e-05	0.000214	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.93e-05	0.000214	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ABCB1—colon cancer	1.93e-05	0.000214	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—TYMS—colon cancer	1.89e-05	0.00021	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—AKT1—colon cancer	1.86e-05	0.000206	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PTGS2—colon cancer	1.84e-05	0.000204	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—FGFR3—colon cancer	1.8e-05	0.000199	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PTGS2—colon cancer	1.79e-05	0.000198	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PIK3CA—colon cancer	1.78e-05	0.000197	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PIK3CA—colon cancer	1.75e-05	0.000194	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—colon cancer	1.72e-05	0.00019	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PPARG—colon cancer	1.7e-05	0.000188	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PPARG—colon cancer	1.65e-05	0.000183	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—APC—colon cancer	1.65e-05	0.000183	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HRAS—colon cancer	1.64e-05	0.000182	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—AKT1—colon cancer	1.64e-05	0.000182	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTGS2—colon cancer	1.64e-05	0.000181	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.61e-05	0.000178	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CTNNB1—colon cancer	1.6e-05	0.000177	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.59e-05	0.000176	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ABCB1—colon cancer	1.57e-05	0.000174	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CDKN1A—colon cancer	1.56e-05	0.000173	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—BRAF—colon cancer	1.55e-05	0.000172	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—TYMS—colon cancer	1.54e-05	0.000171	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—EP300—colon cancer	1.53e-05	0.000169	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTGS2—colon cancer	1.53e-05	0.000169	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—EP300—colon cancer	1.49e-05	0.000165	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ABCB1—colon cancer	1.49e-05	0.000165	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PIK3CA—colon cancer	1.46e-05	0.000162	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—TYMS—colon cancer	1.46e-05	0.000162	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.46e-05	0.000162	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—AKT1—colon cancer	1.45e-05	0.000161	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—SRC—colon cancer	1.45e-05	0.00016	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—AKT1—colon cancer	1.43e-05	0.000159	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.42e-05	0.000157	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MYC—colon cancer	1.4e-05	0.000155	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NRAS—colon cancer	1.39e-05	0.000154	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—EP300—colon cancer	1.36e-05	0.000151	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PPARG—colon cancer	1.34e-05	0.000149	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTGS2—colon cancer	1.34e-05	0.000148	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTGS2—colon cancer	1.3e-05	0.000144	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MYC—colon cancer	1.3e-05	0.000144	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TGFB1—colon cancer	1.29e-05	0.000143	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.29e-05	0.000143	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—EP300—colon cancer	1.27e-05	0.000141	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—EGFR—colon cancer	1.27e-05	0.00014	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.25e-05	0.000138	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ABCB1—colon cancer	1.2e-05	0.000133	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KRAS—colon cancer	1.2e-05	0.000133	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—AKT1—colon cancer	1.2e-05	0.000132	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.19e-05	0.000132	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—TYMS—colon cancer	1.18e-05	0.00013	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ABCB1—colon cancer	1.17e-05	0.00013	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CASP3—colon cancer	1.16e-05	0.000129	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—TYMS—colon cancer	1.15e-05	0.000128	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCND1—colon cancer	1.13e-05	0.000125	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PIK3CA—colon cancer	1.13e-05	0.000125	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CTNNB1—colon cancer	1.12e-05	0.000124	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.11e-05	0.000123	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—EP300—colon cancer	1.11e-05	0.000123	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.1e-05	0.000122	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PIK3CA—colon cancer	1.1e-05	0.000122	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CDKN1A—colon cancer	1.09e-05	0.000121	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PPARG—colon cancer	1.09e-05	0.000121	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—EP300—colon cancer	1.08e-05	0.00012	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTGS2—colon cancer	1.06e-05	0.000117	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EP300—colon cancer	1.04e-05	0.000115	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.04e-05	0.000115	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PPARG—colon cancer	1.03e-05	0.000115	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HRAS—colon cancer	1.02e-05	0.000113	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.02e-05	0.000112	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ABCB1—colon cancer	1.02e-05	0.000112	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SRC—colon cancer	1.01e-05	0.000112	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PIK3CA—colon cancer	1.01e-05	0.000112	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—TYMS—colon cancer	9.97e-06	0.00011	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—colon cancer	9.87e-06	0.000109	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NRAS—colon cancer	9.75e-06	0.000108	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—AKT1—colon cancer	9.68e-06	0.000107	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PIK3CA—colon cancer	9.4e-06	0.000104	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	9.26e-06	0.000103	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—AKT1—colon cancer	9.24e-06	0.000102	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MYC—colon cancer	9.08e-06	0.000101	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ABCB1—colon cancer	9.06e-06	0.0001	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TGFB1—colon cancer	9.06e-06	0.0001	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—AKT1—colon cancer	8.99e-06	9.96e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—TYMS—colon cancer	8.9e-06	9.86e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EGFR—colon cancer	8.88e-06	9.84e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—EP300—colon cancer	8.78e-06	9.72e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.68e-06	9.61e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTGS2—colon cancer	8.6e-06	9.53e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.45e-06	9.36e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KRAS—colon cancer	8.39e-06	9.29e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PPARG—colon cancer	8.34e-06	9.24e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ABCB1—colon cancer	8.26e-06	9.15e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—AKT1—colon cancer	8.23e-06	9.12e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CA—colon cancer	8.21e-06	9.1e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PPARG—colon cancer	8.16e-06	9.03e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTGS2—colon cancer	8.14e-06	9.01e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—TYMS—colon cancer	8.12e-06	8.99e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CA—colon cancer	7.99e-06	8.85e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CA—colon cancer	7.71e-06	8.54e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.68e-06	8.5e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—AKT1—colon cancer	7.68e-06	8.5e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—colon cancer	7.45e-06	8.26e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.22e-06	8e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—EP300—colon cancer	7.16e-06	7.93e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HRAS—colon cancer	7.13e-06	7.9e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PPARG—colon cancer	7.06e-06	7.83e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ABCB1—colon cancer	7.06e-06	7.82e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—TYMS—colon cancer	6.94e-06	7.68e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.85e-06	7.59e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—EP300—colon cancer	6.77e-06	7.5e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—AKT1—colon cancer	6.71e-06	7.43e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTGS2—colon cancer	6.56e-06	7.27e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—AKT1—colon cancer	6.53e-06	7.23e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CA—colon cancer	6.49e-06	7.19e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTGS2—colon cancer	6.42e-06	7.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PPARG—colon cancer	6.31e-06	6.98e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AKT1—colon cancer	6.3e-06	6.97e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.25e-06	6.92e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PPARG—colon cancer	5.75e-06	6.37e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTGS2—colon cancer	5.56e-06	6.16e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—EP300—colon cancer	5.46e-06	6.05e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ABCB1—colon cancer	5.45e-06	6.04e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—TYMS—colon cancer	5.35e-06	5.93e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.34e-06	5.91e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—EP300—colon cancer	5.34e-06	5.91e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—AKT1—colon cancer	5.3e-06	5.88e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CA—colon cancer	5.29e-06	5.86e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CA—colon cancer	5.01e-06	5.54e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTGS2—colon cancer	4.96e-06	5.49e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PPARG—colon cancer	4.91e-06	5.44e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—EP300—colon cancer	4.62e-06	5.12e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTGS2—colon cancer	4.52e-06	5.01e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AKT1—colon cancer	4.32e-06	4.79e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—EP300—colon cancer	4.13e-06	4.57e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AKT1—colon cancer	4.09e-06	4.53e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CA—colon cancer	4.04e-06	4.47e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CA—colon cancer	3.95e-06	4.37e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTGS2—colon cancer	3.86e-06	4.28e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPARG—colon cancer	3.79e-06	4.2e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—EP300—colon cancer	3.76e-06	4.17e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CA—colon cancer	3.42e-06	3.79e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKT1—colon cancer	3.3e-06	3.65e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKT1—colon cancer	3.22e-06	3.57e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—EP300—colon cancer	3.21e-06	3.56e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CA—colon cancer	3.05e-06	3.38e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTGS2—colon cancer	2.98e-06	3.3e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKT1—colon cancer	2.79e-06	3.09e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CA—colon cancer	2.78e-06	3.08e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKT1—colon cancer	2.49e-06	2.76e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—EP300—colon cancer	2.48e-06	2.75e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CA—colon cancer	2.38e-06	2.63e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKT1—colon cancer	2.27e-06	2.52e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKT1—colon cancer	1.94e-06	2.15e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CA—colon cancer	1.84e-06	2.03e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKT1—colon cancer	1.5e-06	1.66e-05	CbGpPWpGaD
